Recent Updates
Recently added Catalysts
HYFT Positive Sentiment Score: 75/100

MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI

Thursday, July 23, 2026 1 min read
Key Takeaway: MindWalk Holdings Corp. has publicly demonstrated ReefIQ™, its AI drug discovery tool, at AMD's Advancing AI event in San Francisco. This marks the first time ReefIQ™ has been showcased, emphasizing its biological context layer for enhancing AI applications in drug discovery. The demonstration is part of a broader collaboration with AMD.

Market Sentiment Analysis

POSITIVE FACTORS

  • MindWalk showcases innovative AI technology for drug discovery.
  • ReefIQ™ demonstrates potential in biological context for AI applications.
  • The public demonstration highlights collaboration with AMD.

Full Press Release Details

AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #ai--MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public demonstration of ReefIQ™, its biological context layer for AI drug discovery, running on AMD Instinct™ at AMD’s Advancing AI 2026 in San Francisco. MindWalk is featured in the AMD Instinct™ Demo Showcase, appearing in one of four custom demo vignettes, with an accompanying video interview distributed through AMD’s channels. The demonstration is the first

Frequently Asked Questions

What is ReefIQ™?

ReefIQ™ is MindWalk's biological context layer designed for AI drug discovery.

Where was ReefIQ™ demonstrated?

ReefIQ™ was demonstrated at AMD's Advancing AI event in San Francisco.

Who is MindWalk Holdings Corp.?

MindWalk is a Bio-Native AI company focused on AI applications in drug discovery.

What technology does ReefIQ™ utilize?

ReefIQ™ runs on AMD Instinct™ technology for enhanced AI performance.

Tags: HYFT Viatris Investor Conferences Healthcare MindWalk ReefIQ AI drug discovery AMD
Last updated: Jul 23, 2026